PapersPMID:35431994
Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Population, every finding
- adults, mostly obese and diabetic patients, RSV vs placebo, pooled from 25 RCTs (1,171 participants)
What moved
How to read these marks →“There was a significant decrease following RSV administration in WC with an SMD of –0.36 (95% CI: –0.59 to –0.14; P = 0.002; I2 = 88%), hemoglobin A1c (HbA1c): –0.48 (–0.69 to –0.2; P ≤ 0.001; I2 = 94%), TC: –0.15 (–0.3 to –0.01; P = 0.003; I2 = 94%), low-density lipoprotein cholesterol (LDL-C): –0.42 (–0.57 to –0.27; P ≤ 0.001; I2 = 92%), and HDL-C:0.16 (–0.31 to –0.02; P = 0.03; I2 = 81%).”
- Decreases LDL cholesterol
moderatereplicated ×2
- Effect
- −0.42 standardised mean difference, 95% CI −0.57 to −0.27
- Decreases glycated haemoglobin (HbA1c)
moderatereplicated ×3
- Effect
- −0.48 standardised mean difference, 95% CI −0.69 to −0.2
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with obesity, type 2 diabetes mellitus, or other metabolic conditions
- Participants
- 1,171
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 70
resveratrol